Scivillage.com Casual Discussion Science Forum
Growing number of nations suspend AstraZeneca covid vaccine (fashionable paranoia) - Printable Version

+- Scivillage.com Casual Discussion Science Forum (https://www.scivillage.com)
+-- Forum: Culture (https://www.scivillage.com/forum-49.html)
+--- Forum: Style & Fashion (https://www.scivillage.com/forum-132.html)
+--- Thread: Growing number of nations suspend AstraZeneca covid vaccine (fashionable paranoia) (/thread-9957.html)



Growing number of nations suspend AstraZeneca covid vaccine (fashionable paranoia) - C C - Mar 14, 2021

https://www.forbes.com/sites/jonathanponciano/2021/03/14/astrazeneca-covid-vaccines-blood-clot-concerns/

EXCERPTS: Ireland became the latest country on Sunday to suspend the administration of the Covid-19 vaccine developed by AstraZenaca and Oxford University after a Norwegian regulator reported a few recipients developed blood clots following their doses–mirroring developments in other countries that have taken similar precautions as the vaccine remains under clinical trials in the United States.

[...] Other countries, including Iceland, Denmark and Norway, suspended their administration of the AstraZeneca vaccine last week on separate concerns over blood clotting, but the World Health Organization and regional authorities have said there is no evidence the vaccines caused the coagulation. ... Meanwhile, northern Italy's Piedmont region, which counts some 4 million residents, also suspended its use of the AstraZeneca vaccine on Sunday after a teacher who had received the shot died on Saturday, Reuters reported, following two deaths under similar conditions reported in nearby Sicily.

Domestically, the AstraZeneca vaccine is still undergoing phase-three clinical trials and has therefore not been approved by the U.S. Food and Drug Administration, but the New York Times reported Friday that the federal government has purchased roughly 30 million doses that are being packaged in an Ohio facility.

[...] The AstraZeneca Covid-19 vaccine, developed in conjunction with Oxford University, has faced more scrutiny than its three approved counterparts in the U.S. (those developed by Pfizer, Moderna and Johnson & Johnson). ... the trials ... have [...shown it...] to be about 82% effective at preventing the most common Covid-19 strain. ... Its fate in the U.S., however, remains in limbo, with no concrete plans for emergency authorization to date.

President Joe Biden on Thursday directed all 50 states to drop their eligibility requirements for Covid-19 vaccines by May 1, effectively opening up shots to every American adult who wants one. As of Sunday, 106 million vaccines have been administered, according to the CDC... (MORE - details)